GlassScriptPhysician profile
Abrar Ahmad
NPI 1346270634
$2,261.21
in general payments reported to CMS, 2019-2025
17 companies · $80.60 in 2025
The $80.60 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $226 · 2021: $161 · 2022: $19.63 · 2023: $120 · 2024: $407 · 2025: $80.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $263.98 | 2019-2023 | Xarelto |
| Abbvie INC. | $252.20 | 2024-2025 | |
| Astellas Pharma US INC | $224.29 | 2019-2021 | |
| Vifor Pharma, INC. | $201.51 | 2019-2023 | Veltassa |
| Gilead Sciences, INC. | $177.53 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $169.69 | 2019-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $152.52 | 2019-2020 | |
| Pfizer INC. | $137.74 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.24 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $112.99 | 2019-2023 | Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $76.18 | 2019 | |
| Csl Behring | $75.85 | 2019 | |
| Paratek Pharmaceuticals, INC. | $52.37 | 2020-2024 | Nuzyra |
| Cumberland Pharmaceuticals, INC. | $51.12 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $46.31 | 2019 | |
| Insmed, INC. | $26.15 | 2023 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abrar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.